Document is current

Any future updates will be listed below

Bemarituzumab enters the FIGHT

Crossref DOI link: https://doi.org/10.1038/s41571-022-00705-2

Published Online: 2022-11-02

Published Print: 2023-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark